JAB-BX400

N/A

Report date: 2024/04/01 14:31:07

Base Information

Drug NameJAB-BX400

Drug Alias NameJAB-BX400

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonistsStimulator of interferon genes stimulants

TargetsReceptor protein-tyrosine kinase erbB-2Stimulator of interferon genes

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesJacobio Pharmaceuticals Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesJacobio Pharmaceuticals Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A